Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events (Q73370304)
Jump to navigation
Jump to search
scientific article published on 01 November 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events |
scientific article published on 01 November 2000 |
Statements
Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events (English)
Goebel J
Stevens E
Forrest K
1 November 2000